Fuchino; Kouki

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fuchino; Kouki.The latest application filed is for "bicyclic heterocycle derivatives having selective bace1 inhibitory activity".

Company Profile

1.8.14

Fuchino; Kouki - Osaka JP
FUCHINO; Kouki - Osaka-shi JP
FUCHINO; Kouki - Toyonaka JP
FUCHINO; Kouki - Fukishima-ku JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical salts of substituted-quinoxaline-type bridged-piperidine compounds Grant 11,111,246 - Yao , et al. September 7, 2	2021-09-07
Bicyclic Heterocycle Derivatives Having Selective Bace1 Inhibitory Activity App 20210261561 - UENO; Tatsuhiko ; et al.	2021-08-26
Substituted-quinoxaline-type Bridged-piperidine Compounds And The Uses Thereof App 20200223847 - Yao; Jiangchao ; et al.	2020-07-16
9'-Aza[3,9'-bi(bicyclo[3.3.1]nonan)]-3'-one and preparation thereof Grant 10,519,156 - Yao , et al. Dec	2019-12-31
Substituted-Quinoxaline-Type Bridged-Piperidine Compounds and the Uses Thereof App 20180370971 - Yao; Jiangchao ; et al.	2018-12-27
Substituted-Quinoxaline-Type Bridged-Piperidine Compounds and the Uses Thereof App 20180148449 - Yao; Jiangchao ; et al.	2018-05-31
Dihydrooxazine or oxazepine derivatives having BACE1 inhibitory activity Grant 9,758,513 - Kusakabe , et al. September 12, 2	2017-09-12
Dihydrothiazine And Dihydrooxazine Derivatives Having Bace1 Inhibitory Activity App 20170073337 - KUSAKABE; Ken-ichi ; et al.	2017-03-16
Dihydrooxazine Or Oxazepine Derivatives Having Bace1 Inhibitory Activity App 20170008881 - KUSAKABE; Ken-ichi ; et al.	2017-01-12
Dihydrooxazine or oxazepine derivatives having BACE1 inhibitory activity Grant 9,540,359 - Kusakabe , et al. January 10, 2	2017-01-10
Substituted-quinoxaline-type piperidine compounds and the uses thereof Grant 9,527,840 - Fuchino , et al. December 27, 2	2016-12-27
Substituted-quinoxaline-type Piperidine Compounds And The Uses Thereof App 20160159785 - FUCHINO; Kouki ; et al.	2016-06-09
Substituted-quinoxaline-type piperidine compounds and the uses thereof Grant 9,278,967 - Fuchino , et al. March 8, 2	2016-03-08
Substituted-quinoxaline-type Bridged-piperidine Compounds And The Uses Thereof App 20160009717 - FUCHINO; Kouki ; et al.	2016-01-14
Dihydrooxazine Or Oxazepine Derivatives Having Bace1 Inhibitory Activity App 20150266865 - Kusakabe; Ken-ichi ; et al.	2015-09-24
Substituted-quinoxaline-type Piperidine Compounds And The Uses Thereof App 20150141643 - FUCHINO; Kouki ; et al.	2015-05-21
Substituted-quinoxaline-type piperidine compounds and the uses thereof Grant 8,846,929 - Fuchino , et al. September 30, 2	2014-09-30
Substituted-quinoxaline-type Bridged-piperidine Compounds And The Uses Thereof App 20130274265 - FUCHINO; Kouki ; et al.	2013-10-17
Fused Heterocyclic Compound Having Amino Group App 20120245155 - Yoshida; Syuhei ; et al.	2012-09-27
Substituted-quinoxaline-type Bridged-piperidine Compounds And The Uses Thereof App 20110178090 - FUCHINO; Kouki ; et al.	2011-07-21
Substituted-Quinoxaline-Type Piperidine Compounds and the Uses Thereof App 20100216726 - FUCHINO; Kouki ; et al.	2010-08-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.